BioLineRx (BLRX) Non Operating Income (2013 - 2026)

BioLineRx's Non Operating Income history runs 13 years deep, the most recent figure standing at $1.1 million for Q4 2025.

• In Q4 2025, Non Operating Income fell 79.06% year-over-year to $1.1 million; the TTM figure through Dec 2025 stood at $8.1 million (down 56.19% YoY), while the FY2025 annual figure was $8.1 million, down 56.19% from the prior year.
• Non Operating Income for Q4 2025 stood at $1.1 million, down from $1.2 million in the prior quarter.
• The five-year high for Non Operating Income was $7.8 million in Q2 2024, with the low at -$7.7 million in Q2 2023.
• The 5-year median for Non Operating Income is $941500.0 (2024), against an average of $976650.0.
• The sharpest annual moves came in 2022 and 2023: Non Operating Income surged 311.06% in 2022, then sank 1788.43% in 2023.
• BioLineRx's Non Operating Income stood at $2.2 million in 2021, then surged by 58.85% to $3.6 million in 2022, then declined by 16.43% to $3.0 million in 2023, then surged by 81.15% to $5.4 million in 2024, then slumped by 79.06% to $1.1 million in 2025.
• Business Quant data shows BLRX's Non Operating Income at $1.1 million in Q4 2025, $1.2 million in Q3 2025, and -$1.9 million in Q2 2025.